Taplmmune, Inc. is a biotechnology company focused on developing innovative cell based immunotherapeutics and vaccines in the areas of oncology and infectious disease. The company’s lead product candidate, the AdhTAP vaccine, is designed to restore and augment antigen presentation and subsequent recognition and killing of cancer cells by the immune system.
Taplmmune’s technologies have been featured on ABC News BusinessNow, B-TV, in BusinessWeek, Popular Mechanics and local newspapers as well as many respected medical journals, including the Journal of Immunology, Nature (Biotechnology), International Journal of Cancer, Cancer Research and PLoS Pathogens, among others.
Let us hear your thoughts: TapImmune, Inc. Message Board
